AR104157A1 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA - Google Patents
COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIAInfo
- Publication number
- AR104157A1 AR104157A1 ARP160100872A ARP160100872A AR104157A1 AR 104157 A1 AR104157 A1 AR 104157A1 AR P160100872 A ARP160100872 A AR P160100872A AR P160100872 A ARP160100872 A AR P160100872A AR 104157 A1 AR104157 A1 AR 104157A1
- Authority
- AR
- Argentina
- Prior art keywords
- anemia
- treatment
- compositions
- methods
- kidney disease
- Prior art date
Links
- 208000007502 anemia Diseases 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title 1
- 208000020832 chronic kidney disease Diseases 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 229940113151 HIF prolyl hydroxylase inhibitor Drugs 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 238000000502 dialysis Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- YOZBGTLTNGAVFU-UHFFFAOYSA-N roxadustat Chemical compound C1=C2C(C)=NC(C(=O)NCC(O)=O)=C(O)C2=CC=C1OC1=CC=CC=C1 YOZBGTLTNGAVFU-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Dosis específicas de, y regímenes de dosificación para, por el uso de un inhibidor de prolil hidroxilasa de HIF en el tratamiento o la prevención de la anemia, tal como la anemia secundaria a o asociada con la enfermedad renal crónica, la anemia secundaria a o asociada con la enfermedad renal crónica no dependiente de diálisis, la anemia asociada con o que resulta de la quimioterapia o la anemia asociada con el SIDA.Specific doses of, and dosage regimens for, by the use of a HIF prolyl hydroxylase inhibitor in the treatment or prevention of anemia, such as anemia secondary to or associated with chronic kidney disease, anemia secondary to or associated with chronic kidney disease not dependent on dialysis, anemia associated with or resulting from chemotherapy or anemia associated with AIDS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562141420P | 2015-04-01 | 2015-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR104157A1 true AR104157A1 (en) | 2017-06-28 |
Family
ID=59256469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP160100872A AR104157A1 (en) | 2015-04-01 | 2016-03-31 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR104157A1 (en) |
-
2016
- 2016-03-31 AR ARP160100872A patent/AR104157A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017011200A2 (en) | Compositions and methods for the treatment of anemia | |
| ECSP20058592A (en) | COMPOSITIONS AND METHODS TO TREAT ANEMIA | |
| EA201692285A8 (en) | EZH2 INHIBITORS FOR TREATING LYMPHOMA | |
| EA201692204A1 (en) | COMPOSITIONS AND METHODS OF MODULATING THE EXPRESSION OF COMPLEX B FACTOR | |
| BR112017002675A2 (en) | methods for improving myocardial performance in fontan patients using udenafil compositions | |
| AR104157A1 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF THE ANEMIA | |
| CR20150660A (en) | COMPOSITIONS AND METHODS TO TREAT ANEMIA | |
| BR112018070526A2 (en) | Renal cell carcinoma treatment with lenvatinib and everolimus | |
| TW202602440A (en) | Compositions and methods for treating anemia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |